ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (ending).

/pdf/esc-guidelines-for-the-diagnosis-and-treatment-of-acute-and-1bgpp8m4g3.pdf

Esc guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (ending)

/pdf/2021-esc-guidelines-on-cardiac-pacing-and-cardiac-kz0aans6lp.pdf

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy.

2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapyDeveloped by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) With the special contribution of the European Heart Rhythm Association (EHRA)

2019 ESC Guidelines for the management of patients with supraventricular tachycardia : The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC)

2019 ESC Guidelines for themanagement of patients with supraventricular tachycardia

Left Bundle Branch Area Pacing for Cardiac Resynchronization Therapy: Results From the International LBBAP Collaborative Study Group.

/pdf/electrocardiographic-manifestations-of-patients-with-3wj9k7evvm.pdf

Electrocardiographic manifestations of patients with cardiogenic shock due to acute pulmonary embolism

BackgroundDuring permanent deep septal pacing, it is important to confirm left bundle branch (LBB) capture.nnObjectiveThe effective refractory period (ERP) of the working myocardium is different than the ERP of the LBB; we hypothesized that it should be possible to differentiate LBB capture from septal myocardial capture using programmed extra-stimulus technique.nnMethodsIn consecutive patients undergoing pacemaker implantation who received pacing lead in a deep septal position programmed pacing was delivered from this lead. Responses to programmed pacing were categorized on the basis of QRS morphology of the extrastimuli as: myocardial (broader QRS, often slurred), selective (narrower QRS, preceded by an isoelectric interval) or non-diagnostic (unequivocal change).nnResultsProgrammed deep septal pacing was performed 269 times in 143 patients; in every patient with the use of an 8-beat basic drive train of 600 ms and when possible also during supraventricular rhythm. Responses diagnostic for LBB capture were observed in 114 (79.7%) of patients. Selective LBB paced QRS was more often seen when premature beats were introduced during the intrinsic rhythm rather than after the basic drive train. The average septal-myocardial refractory period was significantly shorter than the LBB refractory period: 263.0{+/-}34.4 ms vs. 318.0{+/-}37.4 ms.nnConclusionsA novel maneuver for the diagnosis of LBB capture during deep septal pacing, was formulated, assessed and found as diagnostically valuable. This method, based on the differences in refractoriness between LBB and the septal myocardium is unique in enabling the visualization of components of the usually fused, non-selective LBB paced QRS complex.nnGraphical abstract O_FIG_DISPLAY_L [Figure 1] M_FIG_DISPLAY C_FIG_DISPLAY

/pdf/programmed-deep-septal-pacing-for-the-diagnosis-of-left-47fkdjv3lt.pdf

Programmed deep septal pacing for the diagnosis of left bundle branch capture

We present the case of a young patient with significant left ventricular hypertrophy as a common representation of the hypertrophic cardiomyopathy (HCM) phenotype. The clinical presentation and diagnostic route of the disease (despite negative genotype), which can be found in everyday cardiology practice, are shown. Despite the presence of guidelines on this topic, each clinical case is demanding, especially during qualification for invasive procedures. Limited data about the periprocedural risk of catheter ablation and success rate in HCM makes physician decisions for this type of patient challenging. The importance of informed consent and how the patient’s decisions affet further progress are also shown. JRCD 2018; 4 (1): 18-21.

/pdf/hypertrophic-cardiomyopathy-symptomatic-atrial-fibrillation-3aoi13ousu.pdf

Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death (RCD code: V-2A.2)

Paweł Moskal MD | Marek Jastrzębski MD, PhD | Anna Krakowiak MD | Lan Su MD | Weijian Huang MD, FHRS | Danuta Czarnecka MD, PhD First Department of Cardiology, Interventional Electrocardiology and Hypertension, Jagiellonian University Medical College, Krakow, Poland First Department of Cardiology, Interventional Electrocardiology and Hypertension, University Hospital, Krakow, Poland Department of Cardiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China

Marek Jastrzębski

Papers

Electrocardiographic manifestations of patients with cardiogenic shock due to acute pulmonary embolism

Programmed deep septal pacing for the diagnosis of left bundle branch capture

Hypertrophic cardiomyopathy – symptomatic atrial fibrillation in a patient at high risk of sudden cardiac death (RCD code: V-2A.2)

Rate-related block during permanent His bundle pacing.

"Selective" or "exclusive" His bundle capture.